000046925 000__ 01043cam\a22003855i\4500
000046925 001__ 46925
000046925 003__ SzGeWIPO
000046925 005__ 20240708150308.0
000046925 006__ m\\\\eo\\d\\\\\\\\
000046925 007__ cr bn |||m|||a
000046925 008__ 221017s2022\\\\nyu\\\\\o\\\\\000\0\eng\d
000046925 035__ $$a(OCoLC)1348116468
000046925 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046925 041__ $$aeng
000046925 24500 $$aHow Actavis v Lilly has been applied in practice by the English courts and the issues of interpretation that have arisen under it.
000046925 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2022
000046925 300__ $$a1 online resource
000046925 336__ $$atext$$2rdacontent
000046925 337__ $$acomputer$$2rdamedia
000046925 338__ $$aonline resource$$bcr$$2rdacarrier
000046925 4901_ $$aIntellectual Property Quarterly,$$vVolume 1;
000046925 542__ $$fhttps://1.next.westlaw.com/Copyright
000046925 588__ $$aCrossref
000046925 590__ $$aPublished online: 2022
000046925 650_0 $$aIntellectual property.
000046925 650_0 $$aPatent infringement.
000046925 650_0 $$aPatents.
000046925 7001_ $$aTrevor, Cook,$$eauthor.
000046925 7731_ $$tIntellectual Property Quarterly
000046925 7731_ $$wIPQUA
000046925 830_0 $$aIntellectual Property Quarterly;$$vI.P.Q. 2022, 1, 3-18
000046925 85641 $$uhttps://www.westlaw.com/Document/I8B3A7EC0BABB11EC83A9BAB8BFCB759A/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046925 904__ $$aJournal article
000046925 980__ $$aIPQUA